Sudden unexpected death in epilepsy: Knowledge and experience among US and Canadian neurologists

From SUDEP Wiki
Revision as of 20:29, 9 July 2018 by Ycarmen1 (talk | contribs) (Created page with "''Friedman D, Donner EJ, Stephens D, et al. (2014) Sudden unexpected death in epilepsy: Knowledge and experience among US and Canadian neurologists. Epilepsy Behav. 2014 Jun;3...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Friedman D, Donner EJ, Stephens D, et al. (2014) Sudden unexpected death in epilepsy: Knowledge and experience among US and Canadian neurologists. Epilepsy Behav. 2014 Jun;35:13-8.

Link to Article

Abstract: IMPORTANCE: Sudden unexpected death in epilepsy (SUDEP) is a common cause of mortality in patients with the disease, but it is unknown how neurologists disclose this risk when counseling patients. OBJECTIVE: This study aimed at examining SUDEP discussion practices of neurologists in the U.S. and Canada. DESIGN: An electronic, web-based survey was sent to 17,558 neurologists in the U.S. and Canada. Survey questions included frequency of SUDEP discussion, reasons for discussing/not discussing SUDEP, timing of SUDEP discussions, and perceived patient reactions. We examined factors that influence the frequency of SUDEP discussion and perceived patient response using multivariate logistic regression. PARTICIPANTS: The participants of this study were neurologists who completed postgraduate training and devoted >5% of their time to patient care. RESULTS: There was a response rate of 9.3%; 1200 respondents met eligibility criteria and completed surveys. Only 6.8% of the respondents discussed SUDEP with nearly all (>90% of the time) of their patients with epilepsy/caregivers, while 11.6% never discussed it. Factors that independently predicted whether SUDEP was discussed nearly all of the time were the following: number of patients with epilepsy seen annually (OR=2.01, 95% CI=1.20-3.37, p<0.01) and if the respondent had a SUDEP case in the past 24 months (OR=2.27, 95% CI=1.37-3.66, p<0.01). A majority of respondents (59.5%) reported that negative reactions were the most common response to a discussion of SUDEP. Having additional epilepsy/neurophysiology training was associated with an increased risk of a perceived negative response (OR=1.36, 95% CI=1.02-1.82, p=0.038), while years in practice (OR=0.85, 95% CI=0.77-0.95, p<0.005) and seeing both adults and children were associated with a decreased likelihood of negative response (OR=0.15, 95% CI=0.032-0.74, p=0.02). CONCLUSIONS: U.S. and Canadian neurologists rarely discuss SUDEP with all patients with epilepsy/caregivers though discussions are more likely among neurologists who frequently see patients with epilepsy or had a recent SUDEP in their practice. Perceived negative reactions to SUDEP discussions are common but not universal; more experienced neurologists may be less likely to encounter negative reactions, suggesting that there may be ways to frame the discussion that minimizes patient/caregiver distress.

Keywords: Counseling; Disclosure; Education; SUDEP

Context

Comments